AzTrials
AzTrials

Anxiety DisordersNCT02350257

Internet-Based CBT for Children With Anxiety Disorders: Implementation in Clinical Settings

A study testing Internet-based CBT in people with Anxiety Disorders, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary objective of this study is to test the effectiveness of internet-delivered and therapist-guided internet-based cognitive behavior therapy (ICBT) for children with anxiety disorders (including social anxiety disorder, separation anxiety disorder, generalized anxiety disorder, panic disorder and specific… Read more about this study

Who is it for?
Ages 8 to 12 years
Conditions the study is for
Anxiety Disorders
What is being tested?
Internet-based CBT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
131 participants
Where
1 siteSweden
Study dates
Mar 2015to Apr 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • A primary diagnosis of any of the following anxiety disorders, as defined by DSM-V (social anxiety disorder, separation anxiety disorder, generalized anxiety disorder, panic disorder or specific phobia)
  • Age between 8 and 12 years
  • Ability to read and write Swedish
  • Daily access to the internet
  • A parent that is able to co-participate in the treatment
  • Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment

Who cannot join

  • Diagnosed with autism spectrum disorder, psychosis, bipolar disorder or severe eating disorder
  • Present risk of suicide
  • Ongoing substance dependence
  • Completed CBT for any anxiety disorder within the last 6 months (defined as at least 5 sessions of CBT including in vivo exposure sessions)

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • BUP CPF

    Stockholm, 113 30

Other trials in Sweden

About this study

The primary objective of this study is to test the effectiveness of internet-delivered and therapist-guided internet-based cognitive behavior therapy (ICBT) for children with anxiety disorders (including social anxiety disorder, separation anxiety disorder, generalized anxiety disorder, panic disorder and specific phobia) in a randomized trial where participants will be allocated to either ICBT or to a supportive control condition. Non-responders (defined as those participants who still uphold their primary anxiety disorder after the ICBT treatment) will be offered traditional (face-to-face) CBT. Follow-ups are conducted at 3 and 12 months after treatment completion.

Being tested
Internet-based CBT
Keywords
cognitive behavior therapy, child, randomized controlled trial, internet
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Internet-based CBTBehavioural

    12 weeks of internet-based CBT

Study groups in NCT02350257
Study groupRoleWhat they receive
ICBTExperimentalInternet-based cognitive behavior therapy
Receives: Behavioral: Internet-based CBT
Supportive controlNo interventionControl participants has weekly contact with a therapist and receives internet-based training in child directed play. Participants are informed that this training will not likely reduce anxiety.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinician Severity Rating (CSR)

    Change from Baseline of anxiety disorder severity, after 12 weeks and at 3- and 12 months after treatment

    Measured: Baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended

Secondary outcomes (17)
  1. Presence of DSM Anxiety disorder

    Measured: Assessed at Pre, Post, 3-month and 12-month Follow-up

  2. Children´s Globas Assessment Scale (CGAS)

    Measured: Assessed at Pre, Post, 3-month and 12-month Follow-up

  3. Clinical Global Impression - Improvement (CGI-I)

    Measured: Assessed at Post, 3-month and 12-month Follow-up

  4. Revised Children´s Anxiety and Depression Scale - Child version (RCADS-C)

    Measured: Assessed at Pre, Mid-3 weeks, Mid-6 weeks, Mid-9 weeks, Post, 3-month and 12-month Follow-up

  5. Revised Children´s Anxiety and Depression Scale - Parent version (RCADS-P)

    Measured: Assessed at Pre, Mid-3 weeks, Mid-6 weeks, Mid-9 weeks, Post, 3-month and 12-month Follow-up

  6. KIDSCREEN-10 Child version

    Quality of life

    Measured: Assessed at Pre, Post, 3-month and 12-month Follow-up

  7. KIDSCREEN-10 Parent version

    Quality of life

    Measured: Assessed at Pre, Post, 3-month and 12-month Follow-up

  8. Education, Work and Social Adjustment Scale - Child version (EWSAS-C)

    Measured: Assessed at Pre, Mid-6 weeks, Post, 3-month and 12-month Follow-up

  9. Education, Work and Social Adjustment Scale - Parent version (EWSAS-P)

    Measured: Assessed at Pre, Mid-6 weeks, Post, 3-month and 12-month Follow-up

  10. Hospital Anxiety and Depression Scale - Parents (HADS)

    Measured: Assessed at Pre

  11. Technology Acceptance Scale - Child (TAS-C)

    Perceived usefulness and perceived ease of use

    Measured: Assessed at Mid-3 weeks and Post

  12. Technology Acceptance Scale - Parent (TAS-P)

    Perceived usefulness and perceived ease of use

    Measured: Assessed at Mid-3 weeks and Post

  13. Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TIC-P)

    Measured: Assessed at Pre, Post, 3-month and 12-month Follow-up

  14. Measurement of compliance to exposure assignments and anxiety levels, through mobile app

    Participants register anxiety levels in adjunction to exposure exercises, with a smartphone app

    Measured: During the 12 weeks of ICBT

  15. Unintended treatment effects

    Measured: Assessed at Post

  16. Specific Phobia Questionnaire - Child version (SPQ-C)

    Measured: Assessed at Pre, Mid-3 weeks, Mid-6 weeks, Mid-9 weeks, Post, 3-month and 12-month Follow-up

  17. Specific Phobia Questionnaire - Parent version (SPQ-P)

    Measured: Assessed at Pre, Mid-3 weeks, Mid-6 weeks, Mid-9 weeks, Post, 3-month and 12-month Follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2015 (estimated)
  2. Study startMar 2015
  3. Primary completionApr 2018
  4. Study completionApr 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
131 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02350257
Sponsor's protocol ID
BIPSY RCT
Status last verified
Sep 2018
First submitted
19 Jan 2015
Last updated
6 Sep 2018
Results posted
No
Data monitoring committee
No

Publications

  • Jolstedt M, Wahlund T, Lenhard F, Ljotsson B, Mataix-Cols D, Nord M, Ost LG, Hogstrom J, Serlachius E, Vigerland S. Efficacy and cost-effectiveness of therapist-guided internet cognitive behavioural therapy for paediatric anxiety disorders: a single-centre, single-blind, randomised controlled trial. Lancet Child Adolesc Health. 2018 Nov;2(11):792-801. doi: 10.1016/S2352-4642(18)30275-X. Epub 2018 Sep 18.

    PubMed 30241993

Questions about this trial

What is this clinical trial studying?

A study testing Internet-based CBT in people with Anxiety Disorders, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinician Severity Rating (CSR) (time frame: Baseline, 12 weeks after treatment starts, 3 and 12 months after treatment has ended). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02350257, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in